Fennec Pharmaceuticals
FENC54
$5.24arrow_drop_down0.94%-$0.05
FENC54
$5.24
arrow_drop_down0.94%Performance History
| Key Stats | |
|---|---|
| Open | $5.27 |
| Prev. Close | $5.29 |
| EPS | 0.07 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $142.84M |
| LOW | HIGH | |
|---|---|---|
| Day Range | 5.18 | 5.28 |
| 52 Week Range | 5.00 | 11.92 |
| Ratios | |
|---|---|
| EPS | 0.07 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Fennec Pharmaceuticals (FENC)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Rostislav Raykov
- Headquarters
- Research Triangle Park
- Employees
- 36
- Exchange
- NASDAQ
Keep an eye on Fennec Pharmaceuticals
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Fennec Pharmaceuticals 's (FENC) price per share?
The current price per share for Fennec Pharmaceuticals (FENC) is $5.24. The stock has seen a price change of -$0.05 recently, indicating a -0.95% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Fennec Pharmaceuticals (FENC)?
For Fennec Pharmaceuticals (FENC), the 52-week high is $11.92, which is 127.48% from the current price. The 52-week low is $5, the current price is 4.8% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Fennec Pharmaceuticals (FENC) a growth stock?
Fennec Pharmaceuticals (FENC) has shown an average price growth of 0.41% over the past three years. It has received a score of 73 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Fennec Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Fennec Pharmaceuticals (FENC) stock price performance year to date (YTD)?
As of the latest data, Fennec Pharmaceuticals (FENC) has a year-to-date price change of -52.88%. Over the past month, the stock has experienced a price change of -6.43%. Over the last three months, the change has been -19.88%. Over the past six months, the figure is -52.66%. Looking at a longer horizon, the five-year price change stands at 7.16%.
help
Is Fennec Pharmaceuticals (FENC) a profitable company?
Fennec Pharmaceuticals (FENC) has a net income of -$16.34M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 94.08% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -69.39% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $21.64M, although specific revenue growth data is currently not available. The gross profit is $20.36M. Operating income is noted at -$13.01M. Furthermore, the EBITDA is $0.
help
What is the market capitalization of Fennec Pharmaceuticals (FENC)?
Fennec Pharmaceuticals (FENC) has a market capitalization of $142.84M. The average daily trading volume is 94.1K, indicating the stock's liquidity and investor engagement.
News
DIRECTORS AND OFFICERS
7/1/2024Fennec Pharmaceuticals Announces Management Change
ANNUAL MEETINGS & SHAREHOLDER RIGHTS
6/25/2024Fennec Announces Results of Annual Meeting
5/14/2024
Adherex Technologies Inc. (FENC) Lags Q1 Earnings Estimates
EARNINGS RELEASES AND OPERATING RESULTS
CONFERENCE CALLS/ WEBCASTS
5/14/2024Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
5/9/2024
Oncternal Therapeutics (ONCT) Reports Q1 Loss, Tops Revenue Estimates
5/8/2024
Marinus Pharmaceuticals (MRNS) Reports Q1 Loss, Lags Revenue Estimates